Roche extends China deal streak with $1B pact for RNAi obesity drug

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 13 Oct, 15:49 UTC

An alliance with Rona Therapeutics adds to a particularly active stretch for Roche and makes the company the latest to bet on medicines that can lower levels of “visceral” fat.

science

Sources

• T2Roche extends China deal streak with $1B pact for RNAi obesity drugBioPharma Dive / Healthcare Dive / MedTech Dive13 Oct, 15:49